对抗疟疾药物候选药物MMV688533的可持续,高效和潜在的成本效益方法
Rahul D Kavthe1, Karthik S Iyer1, Juan C Caravez1
1Department of Chemistry and Biochemistry, University of California Santa Barbara CA 93106 USA lipshutz@chem.ucsb.edu.
Chemical science
|June 16, 2023
概括
对抗疟疾药物MMV688533的新六步合成使用了更绿色的水性菌根条件. 与以前的方法相比,这种改进的工艺显著增加了产量并减少了浪费.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 绿色化学 绿色化学
背景情况:
- 抗疟疾药物候选药物MMV688533需要一个高效和可扩展的合成.
- 之前的制造工艺在产量,溶剂使用和试剂要求方面存在局限性.
研究的目的:
- 开发一个改进的,环保的合成MMV688533.3.
- 为大规模生产优化关键化学转化.
主要方法:
- 一个六步合成路线被设计和执行.
- 关键反应,包括索诺加希拉合和胺键形成,在水性菌根条件下进行.
- 减少了加载和溶剂的使用.
主要成果:
- 合成实现了整体产量的十倍增长 (6.4%至67%).
- 该过程使用ppm的水平,减少材料投入,以及最小的有机溶剂.
- 传统的胺合试剂被淘汰.
结论:
- 报告的6步综合提供了一个显著改进和更绿色的MMV688533.3路线.
- 这种优化过程对于制造抗疟疾药物候选药物来说更加有效和可持续.
相关概念视频
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...